1. Fenton, A, Dupont, E, Tsangaris, T, et al. Does breast cancer subtype impact margin status in patients undergoing partial mastectomy? Virtual poster presentation PS1-15, San Antonio Breast Cancer Symposium; .
Google Scholar | Crossref2. Moran, MS, Schnitt, SJ, Giuliano, AE, et al. Society of Surgical Oncology- American Society for Radiation Oncology consensus guideline on margins for breast conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88(3):553-564.
Google Scholar | Crossref | Medline3. Brennan, MJ . Endocrinology in cancer of the breast. Status and prospects. Am J Clin Pathol. 1975;64(6):797-809.
Google Scholar | Crossref4. Wittliff, JL . Steroid-hormone receptors in breast cancer. Cancer. 1984;53(suppl 3):630-643.
Google Scholar | Crossref5. Prat, A, Pineda, E, Adamo, B et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(2):S26-S35.
Google Scholar | Crossref6. Harlan, LC, Clegg, LX, Abrams, J, Stevens, JL, Ballard-Barbash, R. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol. 2006;24(6): 872-877.
Google Scholar | Crossref7. Barrio, AV, Morrow, M. Appropriate margin for lumpectomy excision of invasive breast cancer. Chin Clin Oncol. 2016;5(3): 35.
Google Scholar | Crossref8. Braunstein, LZ, Taghian, AG, Niemierko, A, et al. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Res Treat. 2017;161(1):173-179.
Google Scholar | Crossref9. Adra, J, Lundstedt, D, Killander, F et al. Distribution of locoregional breast cancer recurrence in relation to postoperative radiation fields and biological subtypes. Int J Radiation Oncol Biol Phys. 2019;105(2):285-295.
Google Scholar | Crossref10. Pan, Z, Zhu, L, Li, Q, et al. Predicting initial margin status in breast cancer patients during breast-conserving surgery. OncoTargets Ther. 2018;11:2627-2635.
Google Scholar | Crossref11. Hotsinpiller, WJ, Everett, AS, Richman, JS, Parker, C, Boggs, DH. Rates of margin positive resection with breast conservation for invasive breast cancer using the NCDB. Breast. 2021;60:86-89.
Google Scholar | Crossref12. Gray, RJ, Pockaj, BA, Garvey, E, Blair, S. Intraoperative margin management in the breast-conserving surgery: A systematic review of the literature. Ann Surg Onc. 2018;25(1):18-27.
Google Scholar | Crossref13. Findlay-Shirras, LJ, Outbih, O, Muzyka, CN, Galloway, K, Hebbard, PC, Nashed, M. Predictors of residual disease after breast conservation surgery. Ann Surg Oncol, 2018;25(7):1936-1942.
Google Scholar | Crossref | Medline14. Sorrentino, L, Agozzino, M, Albasini, S et al. Involved margins after lumpectomy for breast cancer: Always to be re-excised? Surg Oncol. 2019;30:141-146.
Google Scholar | Crossref15. Singer, L, Brown, E, Lanni, T. Margins in breast conserving surgery: The financial cost & potential savings associated with the new margin guidelines. Breast. 2016;28:P1-P4.
Google Scholar | Crossref16. Torabi, R, Hsu, CH, Patel, PN, Dave, H, Bouton, ME, Komenaka, IK. Predictors of margin status after breast-conserving operations in an underscreened population. Lagenbecks Arch Surg. 2013;398(3):455-462.
Google Scholar | Crossref16. Atkins, J, Al Mushawah, F, Appleton, CM, et al. Positive margin rates following breast conserving surgery for stage II-III breast cancer: palpable vs non-palpable tumors. J Surg Res. 2012;177(1):109-115.
Google Scholar | Crossref | Medline17. Skinner, KA, Silberman, H, Sposto, R, Silverstein, MJ. Palpable breast cancers are inherently different from nonpalpable breast cancers. Ann Surg Oncol. 2001;8(9):705-710.
Google Scholar | Crossref18. “Race and hispanic origin.” 2020 Census, United States Census Bureau, 2021, https://www.census.gov/quickfacts/fact/table/US/PST045219. Accessed November 15, 2021.
Google Scholar